Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Rehydra+ Wellness

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rehydra+ Wellness head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 195 · Grade C

Rehydra+ Wellness

Visit Rehydra+ Wellness Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 68 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Rehydra+ Wellness a bad call — it's best for shoppers who want to buy four weeks outright before deciding, or who are certain enough to lock in six months. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
72
Transparency
90
94
Access Breadth
93
64
Clinical Oversight
92
72
Track Record
88
59
CoreAge RxBrief Score 94 · 68Rehydra+ Wellness

Price, coverage & the tracker

CoreAge RxRehydra+ Wellness
Brief Score94/100 (A)68/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not publishedFrom $149/mo (starting dose, one-time purchase, 28-day cycle, compounded)
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not publishedFrom $219/mo (starting dose, one-time purchase, 28-day cycle, compounded)
CoverageUS only; restrictions by state, confirmed at intake19 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Rehydra+ Wellness: New to the tracker on 1 September 2026, and read on the provider's own site rather than taken on trust: we checked https://www.rehydraplus.com/ on 2026-09-01 and this row reflects what that page says. The line we publish is From $149/mo (starting dose, one-time purchase, 28-day cycle, compounded). There is no earlier reading of ours to compare it against yet.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.